Improving lung cancer monitoring and outcomes for diverse populations
Official title: Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
Funded at University of Florida · NIH-10881972 · Data updated 2026-11-12
This study is looking to improve how we keep an eye on and support patients with early-stage lung cancer after their treatment, by gathering real-life information to help create better follow-up care recommendations.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | July 5, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $497,819 |
| NIH project number | 5R01CA284646-02 |
| Project ID | NIH-10881972 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with early-stage non-small cell lung cancer who have undergone curative-intent therapy.
✕Less likely to help
Patients with advanced-stage lung cancer or those who have not received curative treatment may not benefit from this research.
What this research studies
This research focuses on enhancing lung cancer surveillance and outcomes for patients with early-stage non-small cell lung cancer (NSCLC). It aims to create a comprehensive data source that tracks real-world patterns of lung cancer surveillance and the resulting health outcomes. By analyzing this data, the project seeks to develop evidence-based recommendations for monitoring patients after curative treatment. The research will utilize existing infrastructure from a clinical research consortium that serves multiple states, ensuring a diverse population is represented.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring strategies that enhance survival rates and quality of life for lung cancer patients.
How similar studies have gone: While there is ongoing research in lung cancer surveillance, this project aims to fill a significant gap in understanding real-world outcomes, making it a novel approach.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Braithwaite, Dejana K — University of Florida
- Study coordinator: Braithwaite, Dejana K
Related research
Other NIH-funded projects on the same topics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Integrative Analysis of Lung Cancer Risk and Its Causes
A large, multi-part study at the University of New Mexico is exploring why lung cancer happens and how to better prevent and detect it.
-
Integrative Analysis of Lung Cancer Risk and Causes
A large NIH project is exploring how tobacco use, behavior, biology, and screening practices influence lung cancer risk and outcomes to help prevent and detect it earlier.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Proteomics-guided matching of lung cancer tumors to preclinical models
This grant aims to improve how we match a patient’s lung cancer tumor to the right preclinical models using protein data.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.